Endocrine Abstracts

Previous UK guidelines (2002, 2007) focused on reducing regional variations in practice, concentrating expertise (especially surgical), and eliminating clinical, radiological and biochemical evidence of persistent disease. The 2014 guidelines aim to improve the overall survival while enhancing the health-related quality of life of patients. This presentation will discuss areas of the guidelines that are significantly different from the previous edition of the guidelines and are most relevant to practicing endocrinologists: i) entry of patients into the cancer pathway and initial investigation of thyroid nodules, ii) management of micorcarcinomas, iii) managing uncertainty, and iv) patient quality of life.